Abstract:Summary Background 2019-Novel coronavirus (2019-nCoV) outbreaks create challenges for hospital laboratories because thousands of samples must be evaluated each day. Sample types, interpretation methods, and corresponding laboratory standards must be established. The possibility of other infections should be assessed to provide a basis for clinical classification, isolation, and treatment. Accordingly, in the present study, we evaluated the testing methods for 2019-nCoV and co-infections. Methods We used a fluorescence-based quantitative PCR kit urgently distributed by the Chinese CDC to detect 8274 close contacts in the Wuhan region against two loci on the 2019-nCoV genome. We also analyzed 613 patients with fever who underwent multiple tests for 13 respiratory pathogens; 316 subjects were also tested for 2019-nCoV. Findings Among the 8274 subjects, 2745 (33.2%) had 2019-nCoV infection; 5277 (63.8%) subjects showed negative results in the 2019-nCoV nucleic acid test (non-2019-nCoV); and 252 cases (3.0%) because only one target was positive, the diagnosis was not definitive. Eleven patients who originally had only one positive target were re-examined a few days later; 9 patients (81.8%) were finally defined as 2019-nCoV-positive, and 2 (18.2%) were finally defined as negative. The positive rates of nCoV-NP and nCovORF1ab were 34.7% and 34.7%, respectively. nCoV-NP-positive only and nCovORF1ab-positive cases accounted for 1.5% and 1.5%, respectively. In the 316 patients with multiple respiratory pathogens, 104 were positive for 2019-nCov and 6/104 had co-infection with coronavirus (3/104), influenza A virus (2/104), rhinovirus (2/104), and influenza A H3N2 (1/104); the remaining 212 patients had influenza A virus (11/202), influenza A H3N2 (11/202), rhinovirus (10/202), respiratory syncytial virus (7/202), influenza B virus (6/202), metapneumovirus (4/202), and coronavirus (2/202). Interpretation Clinical testing methods for 2019-nCoV require improvement. Importantly, 5.8% of 2019-nCoV infected and 18.4% of non-2019-nCoV-infected patients had other pathogen infections. It is important to treat combined infections and perform rapid screening to avoid cross-contamination of patients. A test that quickly and simultaneously screens as many pathogens as possible is needed. Funding No founding was received Research in context Evidence before this study We searched PubMed for articles published up to January 31, 2020 using the keywords “2019 novel coronavirus” or “2019-nCoV”. No published study on the characteristics of 2019-nCoV tests or 2019-nCoV co-infections was found. We only noted recent laboratory findings for other tests of patients infected with 2019-nCoV. Added value of this study Positive detection of nCoV-NP or nCovORF1ab is presented, and individuals with/without 2019-nCoV infections or with inconclusive results were identified. Patients with inconclusive results may be diagnosed with 2019-nCoV infection or found to be negative for the infection after resampling and retesting in the next few days. Approximately 5.8% of the subjects diagnosed with 2019-nCoV had co-infection. Implications of all the available evidence Management of the population showing inconclusive results should be given attention; additionally, such results can be minimized by improving the sampling, sample pretreatment, and testing methodologies. When diagnosing 2019-nCoV subjects, the possibility of co-infection should be considered. Finally, better clinical detection methods are needed to simultaneously screen as many pathogens as possible.

Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients

Analysis of Blood Index Characteristics in COVID-19 Patients and Their Associations with Different Outcomes

Analysis of factors associated early diagnosis in coronavirus disease 2019 (COVID-19)

Retrospective analysis of the clinical features of outpatients with novel coronavirus in areas outside Wuhan, China

Epidemiological, Clinical, Laboratorial and CT Imaging Features of Hospitalized Patients with Initially Negative Detection of SARS-CoV-2 in China

Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19)

The Clinical and Radiological Manifestations in Coronavirus Disease 2019 with Negative Nucleic Acid Results.

Predictors of COVID-19 Infection: A Prevalence Study of Hospitalized Patients

Detection and analysis of nucleic acid in various biological samples of COVID-19 patients

A Cross-Sectional Comparative Characterization of Hematological Changes in Patients with COVID-19 Infection, Non-COVID Influenza-like Illnesses and Healthy Controls

A Retrospective and Multicenter Study on COVID-19 in Inner Mongolia: Evaluating the Influence of Sampling Locations on Nucleic Acid Test and the Dynamics of Clinical and Prognostic Indexes

Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients

Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan

Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19

Comparative study of hematological and radiological feature of severe/critically ill patients with COVID‐19, influenza A H7N9, and H1N1 pneumonia

Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters

Analysis of 2019 novel coronavirus infection and clinical characteristics of outpatients: An epidemiological study from a fever clinic in Wuhan, China

Hematological characteristics of patients with novel coronavirus pneumonia in intensive care unit

Role of hematological parameters in the diagnosis of influenza virus infection in patients with respiratory tract infection symptoms

Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients

Optimizing Screening Strategies for Coronavirus Disease 2019: A Study from Middle China